SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-05-189780
Filing Date
2005-09-22
Accepted
2005-09-22 12:30:45
Documents
5
Period of Report
2005-10-27
Effectiveness Date
2005-09-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 248198
2 GRAPHIC g18872g45u41.jpg GRAPHIC 71644
3 GRAPHIC g18872g84t58.jpg GRAPHIC 4653
4 GRAPHIC g18872pc1.jpg GRAPHIC 159401
5 GRAPHIC g18872pc2.jpg GRAPHIC 133942
  Complete submission text file 0001193125-05-189780.txt   759615
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
Monogram Biosciences, Inc. (Filer) CIK: 0001094961 (see all company filings)

IRS No.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30369 | Film No.: 051097562
SIC: 2835 In Vitro & In Vivo Diagnostic Substances